ENVB Stock Price History and Quote Analysis Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ENVB shares is 16, representing 7.06% of the company's common stock.

ARMISTICE CAPITAL, LLC, in the last quarter, reduced its stake in ENVB by -100% restricting it's holding to 0 shares of worth nearly -. ORG PARTNERS LLC also lessened -100% of the ENVB shares from its portfolio, reducing its holding to 0 shares of worth -. TOWER RESEARCH CAPITAL LLC (TRC) also shunned ENVB shares holding by -3.13% last quarter which brought its holding to 12.28 thousand shares worth $12.28K.

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in ENVB by 100% in the last quarter. The institutional holder raised its holding to 40.1 thousand shares having worth more than $40.10K. SUSQUEHANNA INTERNATIONAL GROUP, LLP also added 100% more shares of ENVB to its portfolio, raising its holding to 18.25 thousand shares of worth $18.25K. WELLS FARGO & COMPANY/MN also increased its ENVB shares holding by 12.12% which brought its holding to 37 shares worth $37.00.

The insider with the most stakes in ENVB is N/A , N/A at the company. Additionally, ENVB stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 6.93% percent of Enveric Biosciences, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ENVB insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SIKARIA FAMILY 2008 REVOCABLE TRUST DATED 02/28/2008, SIKARIA LOKESH, and SIKARIA CHANDA.

There have been 0 transaction(s) during the past 6-months in which Enveric Biosciences, Inc. insiders have bought stock, totalling 0 shares

Around 0 Enveric Biosciences, Inc. shares are held by insiders, which represents about 6.93% of ENVB stock.

ENVB N/A, N/A holds the largest portfolio of the company's shares. ENVB shares owned by N/A total nearly -.

CITADEL ADVISORS LLC is the largest institutional owner in ENVB which holds 40.1 thousand shares worth $40.10K or 1.86% of the total ENVB shares outstanding followed by BLACKROCK INC. with ownership of 29.58 thousand shares representing 1.37% of the ENVB ownership. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the third largest stakeholder with 18.25 thousand shares or 0.85% of the ownership worth more than $18.25K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ENVB is concerned, it is a stock which is not optionable.

Number of ENVB shares short is 193.18K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 8.92M shares of ENVB are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ENVB has 8.64M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ENVB is 0.19.